Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery Indian Medical PG Practice Questions and MCQs

Question 301: Which of the following is NOT an indication for cholecystectomy for gallstone disease?

A. Asymptomatic gallstones with diabetes mellitus (Correct Answer)
B. Porcelain gallbladder
C. Asymptomatic with a history of a single attack of acute pancreatitis
D. Symptomatic cholecystitis

Explanation: **Explanation:** The management of gallstone disease is primarily guided by the presence of symptoms or specific risk factors for malignancy. **1. Why Option A is the Correct Answer:** Historically, **Diabetes Mellitus** was considered an indication for prophylactic cholecystectomy due to fears of rapidly progressing gangrenous cholecystitis. However, current evidence and guidelines (including Bailey & Love) state that the risk of complications in diabetics is not significantly higher than in non-diabetics. Therefore, **asymptomatic gallstones in a diabetic patient are NOT an indication for surgery** unless other specific criteria are met. **2. Why the other options are wrong (Indications for Surgery):** * **Porcelain Gallbladder (Option B):** This refers to intramural calcification of the gallbladder wall. It is an absolute indication for cholecystectomy due to its strong association with gallbladder carcinoma (up to 12-25% risk). * **History of Acute Pancreatitis (Option C):** Even a single attack of gallstone pancreatitis warrants cholecystectomy (ideally during the same admission) to prevent recurrent, potentially fatal episodes. * **Symptomatic Cholecystitis (Option D):** This is the most common indication. Once gallstones become symptomatic (biliary colic or cholecystitis), the risk of recurrent symptoms and complications increases significantly. **Clinical Pearls for NEET-PG:** * **Indications for Prophylactic Cholecystectomy in Asymptomatic Patients:** 1. Gallstones > 3 cm (increased risk of malignancy). 2. Porcelain gallbladder. 3. Gallstones associated with a hemolytic anemia (e.g., Hereditary Spherocytosis) to prevent future pigment stones. 4. Anomalous pancreaticobiliary ductal union. 5. Gallbladder polyps > 10 mm. * **Gold Standard Investigation:** Ultrasound of the abdomen (95% sensitivity for stones). * **Treatment of Choice:** Laparoscopic Cholecystectomy.

Question 302: Which tumor marker is most frequently elevated in carcinoma of the gall bladder?

A. Alpha fetoprotein (AFP)
B. CA 125
C. CA 19-9 (Correct Answer)
D. Carcino-Embryonic Antigen (CEA)

Explanation: **Explanation:** **Carcinoma of the Gallbladder (GBC)** is the most common biliary tract malignancy. While no tumor marker is 100% specific for GBC, **CA 19-9 (Carbohydrate Antigen 19-9)** is the most frequently elevated and clinically utilized marker for its diagnosis and monitoring. 1. **Why CA 19-9 is correct:** CA 19-9 is a sialylated Lewis antigen typically associated with pancreatobiliary malignancies. In GBC, it has a high sensitivity (approx. 70-80%). It is particularly useful for monitoring treatment response and detecting recurrence, though its levels can also rise in benign conditions like obstructive jaundice or cholangitis. 2. **Why other options are incorrect:** * **Alpha-fetoprotein (AFP):** This is the primary marker for **Hepatocellular Carcinoma (HCC)** and certain germ cell tumors (e.g., Yolk sac tumor). It is not associated with gallbladder epithelium. * **CA 125:** While it can be elevated in various intra-abdominal malignancies, it is the classic marker for **Ovarian Cancer**. * **CEA (Carcino-Embryonic Antigen):** CEA is frequently elevated in GBC (sensitivity ~50%), but it is less sensitive and less specific than CA 19-9. It is primarily used for **Colorectal Carcinoma**. **High-Yield Clinical Pearls for NEET-PG:** * **Most common histological type:** Adenocarcinoma (90%). * **Most common risk factor:** Cholelithiasis (Gallstones), especially stones >3 cm. * **Porcelain Gallbladder:** Calcification of the GB wall; carries a significant risk of malignancy (though recent studies suggest the risk is lower than previously thought, it remains a high-yield exam fact). * **Nevin’s Staging / AJCC Staging:** Crucial for determining resectability. * **Investigation of Choice:** Contrast-Enhanced CT (CECT) is the gold standard for staging and assessing resectability.

Question 303: What is the treatment for symptomatic retained gallstones?

A. Sphincterotomy (Correct Answer)
B. Extracorporeal shock wave lithotripsy (ESWL)
C. Laparoscopic removal
D. None of these

Explanation: ### Explanation **Correct Answer: A. Sphincterotomy** **Medical Concept:** Retained gallstones are defined as common bile duct (CBD) stones discovered within two years of a cholecystectomy. For symptomatic patients, the gold standard treatment is **Endoscopic Retrograde Cholangiopancreatography (ERCP) with Endoscopic Sphincterotomy**. This procedure involves cannulating the Ampulla of Vater and performing an electrosurgical incision of the sphincter of Oddi, which allows for the extraction of stones using baskets or balloons. It is preferred because it is minimally invasive, highly effective, and avoids the morbidity of a repeat surgery. **Why Other Options are Incorrect:** * **B. Extracorporeal shock wave lithotripsy (ESWL):** While ESWL can be used for renal stones or occasionally for large gallbladder stones in specific protocols, it is not the primary treatment for CBD stones. It carries risks of biliary colic and pancreatitis if fragments become lodged. * **C. Laparoscopic removal:** Laparoscopic CBD exploration is an excellent option *during* the initial cholecystectomy if stones are found. However, for "retained" stones (post-cholecystectomy), ERCP is the less invasive first-line approach compared to a secondary surgical entry into a scarred operative field. **High-Yield Clinical Pearls for NEET-PG:** * **Retained vs. Recurrent:** Stones found **<2 years** post-surgery are "retained" (missed during surgery); stones found **>2 years** post-surgery are "recurrent" (formed de novo in the duct, usually pigment stones). * **Diagnostic Gold Standard:** MRCP is the most sensitive non-invasive investigation, but ERCP is the **therapeutic gold standard**. * **Post-ERCP Complication:** The most common complication of ERCP is **acute pancreatitis** (approx. 5-10%). * **Alternative:** If ERCP fails, the next step is usually Percutaneous Transhepatic Cholangiography (PTC) or surgical exploration.

Question 304: Which of the following is NOT a risk factor for cholangiocarcinoma?

A. Chronic typhoid carrier state
B. Chronic ulcerative colitis
C. Parasitic infestation
D. Choledocholithiasis (Correct Answer)

Explanation: **Explanation:** The correct answer is **Choledocholithiasis**. While chronic inflammation is the common denominator for most risk factors of cholangiocarcinoma (CCA), simple gallstones in the common bile duct (choledocholithiasis) are not established as a direct independent risk factor. In contrast, **hepatolithiasis** (intrahepatic stones) is a well-known risk factor due to chronic recurrent pyogenic cholangitis. **Analysis of Options:** * **Chronic Typhoid Carrier State (Option A):** Chronic infection with *Salmonella typhi* in the gallbladder or biliary tract leads to chronic inflammation and is associated with an increased risk of both gallbladder cancer and cholangiocarcinoma. * **Chronic Ulcerative Colitis (Option B):** This is strongly associated with **Primary Sclerosing Cholangitis (PSC)**. PSC is the most common predisposing factor for cholangiocarcinoma in Western countries, carrying a lifetime risk of 10-15%. * **Parasitic Infestation (Option C):** Liver flukes, specifically ***Opisthorchis viverrini*** and ***Clonorchis sinensis***, are major risk factors in endemic areas (Southeast Asia). They cause chronic biliary inflammation and DNA damage, leading to malignant transformation. **High-Yield NEET-PG Pearls:** 1. **Choledochal Cysts:** Type I and Type IV cysts have the highest risk of malignant transformation into CCA. 2. **Thorotrast:** A historical radiocontrast agent strongly linked to CCA and hepatic angiosarcoma. 3. **Tumor Marker:** **CA 19-9** is the most commonly used marker for monitoring, though it is also elevated in benign biliary obstruction. 4. **Klatskin Tumor:** A hilar cholangiocarcinoma occurring at the confluence of the right and left hepatic ducts (most common site).

Question 305: Which of the following is NOT an indication for cholecystectomy?

A. Emphysematous cholecystitis
B. Biliary dyskinesia
C. Perforation of gallbladder
D. Adenomyomatosis (Correct Answer)

Explanation: **Explanation:** The decision to perform a cholecystectomy is based on the presence of symptoms, complications, or a high risk of malignancy. **Why Adenomyomatosis is the correct answer:** Adenomyomatosis is a benign condition characterized by hyperplasia of the gallbladder wall and the formation of intramural diverticula known as **Rokitansky-Aschoff sinuses**. In the absence of symptoms (biliary colic) or diagnostic uncertainty regarding malignancy, it is considered a **benign, non-premalignant condition** that does not routinely require surgery. Observation is the standard of care for asymptomatic cases. **Analysis of Incorrect Options:** * **Emphysematous Cholecystitis:** A surgical emergency caused by gas-forming organisms (e.g., *Clostridium perfringens*). It carries a high risk of gangrene and perforation, requiring urgent cholecystectomy. * **Biliary Dyskinesia:** Defined by biliary-type pain with a low Gallbladder Ejection Fraction (typically <35% on HIDA scan) in the absence of stones. Cholecystectomy is the definitive treatment for symptom relief. * **Perforation of Gallbladder:** A life-threatening complication of acute cholecystitis. It requires immediate surgical intervention to manage peritonitis or abscess formation. **NEET-PG High-Yield Pearls:** 1. **Porcelain Gallbladder:** Previously an absolute indication for surgery; current guidelines suggest cholecystectomy only if the calcification is "patchy/incomplete" due to higher gallbladder cancer risk. 2. **Gallbladder Polyps:** Indication for surgery if size is **>10 mm**, if they are symptomatic, or if they are associated with gallstones. 3. **Diabetes & Asymptomatic Stones:** Diabetes is **not** an indication for prophylactic cholecystectomy unless the patient is symptomatic. 4. **Mirizzi Syndrome:** Extrinsic compression of the CBD by a stone in the cystic duct; requires surgical management.

Question 306: A patient with a history of choledocholithiasis presents with elevated conjugated bilirubin. Ultrasound reveals a dilated biliary system up to the terminal part. In case of suspicion of an ampullary obstructive calculus, which of the following investigations would be most sensitive?

A. Percutaneous transhepatic cholangiography (PTC)
B. Magnetic resonance cholangiopancreatography (MRCP)
C. X-ray abdomen
D. Endoscopic ultrasonography (EUS) (Correct Answer)

Explanation: **Explanation:** The patient presents with obstructive jaundice and a dilated biliary system extending to the terminal part, strongly suggesting a pathology at the **Ampulla of Vater** or the distal common bile duct (CBD). **Why EUS is the correct answer:** Endoscopic Ultrasonography (EUS) is currently considered the **most sensitive investigation** (sensitivity >95%) for detecting small common bile duct stones (choledocholithiasis), particularly those located in the distal/ampullary region. Because the transducer is placed in the duodenum, immediately adjacent to the ampulla, it eliminates interference from bowel gas and provides high-resolution images. It is superior to MRCP for detecting "microlithiasis" or stones smaller than 5mm. **Analysis of Incorrect Options:** * **MRCP (Option B):** While MRCP is an excellent non-invasive diagnostic tool with high sensitivity (approx. 85-92%), it is slightly less sensitive than EUS for very small stones (<5mm) or impacted stones at the ampulla due to spatial resolution limits. * **PTC (Option A):** This is an invasive procedure typically reserved for proximal (hilar) biliary obstructions when ERCP is not feasible. It is not the first-line or most sensitive investigation for distal ampullary stones. * **X-ray Abdomen (Option C):** Most gallstones (approx. 85%) are radiolucent (cholesterol stones). X-rays have very low sensitivity for biliary calculi and are not diagnostic. **Clinical Pearls for NEET-PG:** * **Gold Standard for Diagnosis:** ERCP (but it is invasive and now primarily therapeutic). * **Best Initial Investigation:** Transabdominal Ultrasound (USG). * **Most Sensitive Non-invasive Investigation:** MRCP. * **Most Sensitive Investigation Overall:** EUS (especially for distal/small stones). * **Management:** If a stone is confirmed, the treatment of choice is **ERCP with Sphincterotomy** followed by stone extraction.

Question 307: Left-sided portal hypertension is best treated by?

A. Splenectomy (Correct Answer)
B. Portocaval shunt
C. Reno-renal shunt
D. Splenorenal shunt

Explanation: **Explanation:** **Left-sided portal hypertension** (also known as **Sinistral portal hypertension**) is a localized form of portal hypertension caused by **Splenic Vein Thrombosis (SVT)**. Unlike generalized portal hypertension (e.g., Cirrhosis), the liver function and the pressure in the rest of the portal system remain normal. 1. **Why Splenectomy is the Correct Answer:** In SVT, blood from the spleen cannot drain through the splenic vein. It is forced to divert through the short gastric veins into the gastric fundus, forming **isolated gastric varices**, and then into the left gastric vein to reach the portal vein. **Splenectomy** is the definitive treatment because it removes the source of the high-pressure venous outflow (the spleen), thereby decompressing the gastric varices and eliminating the risk of hemorrhage. 2. **Why Other Options are Incorrect:** * **Portocaval, Reno-renal, and Splenorenal shunts:** These are systemic shunting procedures used for **generalized portal hypertension** (e.g., Cirrhosis) to lower overall portal pressure. In left-sided portal hypertension, the portal venous pressure is already normal; therefore, creating a shunt is unnecessary, ineffective, and carries risks like hepatic encephalopathy. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause:** Chronic Pancreatitis (due to the proximity of the splenic vein to the pancreas). Other causes include pancreatic cancer and trauma. * **Classic Presentation:** A patient with a history of pancreatitis presenting with **isolated gastric varices** (esophageal varices are usually absent) and a normal liver profile. * **Diagnostic Gold Standard:** Splenic venography (though CT/MRI angiography is more common clinically). * **Key Distinction:** If the patient is asymptomatic, surgery is often deferred; however, if bleeding occurs, **Splenectomy** is the treatment of choice.

Question 308: What is the most appropriate investigation for the diagnosis of common bile duct stones?

A. Ultrasonography
B. ERCP (Correct Answer)
C. OCG
D. IV cholangiography

Explanation: **Explanation:** The diagnosis and management of common bile duct (CBD) stones (choledocholithiasis) require distinguishing between the initial screening tool and the definitive diagnostic standard. **Why ERCP is the Correct Answer:** **Endoscopic Retrograde Cholangiopancreatography (ERCP)** is traditionally considered the "Gold Standard" for the diagnosis of CBD stones. Its primary advantage is that it is both **diagnostic and therapeutic**. It allows for direct visualization of the biliary tree via fluoroscopy and provides the immediate opportunity for intervention, such as sphincterotomy and stone extraction using baskets or balloons. While Magnetic Resonance Cholangiopancreatography (MRCP) is now the diagnostic investigation of choice due to its non-invasive nature, ERCP remains the correct answer in many standardized exams when "diagnosis" implies the definitive step leading to management. **Analysis of Incorrect Options:** * **A. Ultrasonography (USG):** This is the **initial investigation of choice** for biliary disease. While excellent for detecting gallstones (cholelithiasis) and CBD dilation, it has low sensitivity (approx. 20-50%) for directly visualizing stones within the distal CBD due to interference from overlying bowel gas. * **C. Oral Cholecystography (OCG):** This is an obsolete technique formerly used to visualize the gallbladder. It has no role in the modern diagnosis of CBD stones. * **D. IV Cholangiography:** This historical method has been replaced by modern imaging (CT/MRCP) due to high toxicity of the contrast media and poor visualization in patients with jaundice. **Clinical Pearls for NEET-PG:** * **Initial Investigation:** Transabdominal USG. * **Best Non-invasive Investigation:** MRCP (Sensitivity/Specificity >95%). * **Gold Standard (Diagnostic + Therapeutic):** ERCP. * **Most Sensitive Per-operative Tool:** Intraoperative Ultrasound (IOUS) or Cholangiography (IOC). * **Charcot’s Triad:** Fever, Jaundice, and RUQ pain (indicates Cholangitis due to CBD obstruction).

Question 309: What is the treatment of choice for a choledochal cyst?

A. Roux-en-Y hepaticojejunostomy (Correct Answer)
B. Cystojejunostomy
C. Choledochoduodenostomy
D. Choledochojejunostomy

Explanation: **Explanation:** The treatment of choice for a choledochal cyst (specifically the most common Type I and Type IV) is **complete surgical excision of the cyst followed by biliary reconstruction via Roux-en-Y hepaticojejunostomy.** **Why Roux-en-Y Hepaticojejunostomy is Correct:** The primary goal in managing choledochal cysts is the complete removal of the cyst wall because the cyst lining is prone to **cholangiocarcinoma** (due to chronic inflammation and reflux of pancreatic enzymes). Once the cyst is excised, the biliary tree must be drained. A Roux-en-Y hepaticojejunostomy is preferred because it provides a tension-free anastomosis and, most importantly, prevents the reflux of enteric contents into the biliary tree, reducing the risk of ascending cholangitis. **Why Other Options are Incorrect:** * **Cystojejunostomy (B):** This is an internal drainage procedure that leaves the cyst wall intact. It is now obsolete because it carries a high risk of malignancy in the retained cyst and recurrent stone formation. * **Choledochoduodenostomy (C) & Choledochojejunostomy (D):** These procedures involve anastomosing the bile duct (or cyst) to the duodenum or a loop of jejunum without complete excision. They are avoided due to the high risk of biliary reflux, stricture formation, and the persistent risk of malignancy in the remaining cyst tissue. **NEET-PG High-Yield Pearls:** * **Todani Classification:** Type I (Saccular/Fusiform dilation of CBD) is the most common (80-90%). * **Etiology:** Often associated with an **Anomalous Pancreaticobiliary Duct Junction (APBDJ)**, leading to the reflux of pancreatic juice into the CBD. * **Classic Triad:** Jaundice, right upper quadrant pain, and a palpable mass (present in only 20% of cases, mostly children). * **Gold Standard Investigation:** MRCP is the diagnostic tool of choice. * **Type V (Caroli’s Disease):** If localized, lobectomy is done; if diffuse, liver transplantation is the definitive treatment.

Question 310: Liver tunneling procedures are not performed for which segment?

A. I
B. IV
C. V (Correct Answer)
D. VIII

Explanation: **Explanation:** **Liver tunneling** is a specialized surgical technique used to access deep-seated tumors or lesions located within the liver parenchyma while preserving the overlying functional liver tissue. This procedure is specifically designed for segments that are **deeply situated** or located in the **posterior/superior** aspects of the liver, often near the major hepatic veins or the inferior vena cava (IVC). **Why Segment V is the Correct Answer:** Segment V is located in the **anteroinferior** part of the right lobe. Because it is superficial and easily accessible via the diaphragmatic or visceral surface of the liver, a "tunneling" approach is unnecessary. Lesions in Segment V are typically managed via standard wedge resection or formal segmentectomy. **Analysis of Incorrect Options:** * **Segment I (Caudate Lobe):** This is the most common site for tunneling. It is located deep between the IVC and the portal hepatis. Accessing it often requires tunneling through the overlying parenchyma to avoid major vascular injury. * **Segment IV (specifically IVa):** Located superiorly near the falciform ligament and the middle hepatic vein, deep lesions here often require a tunnel approach to spare the surrounding functional tissue of the left and right lobes. * **Segment VIII:** Situated in the **posterosuperior** aspect of the right lobe, it is one of the most difficult segments to reach. Tunneling is frequently employed here to reach tumors located near the confluence of the hepatic veins. **Clinical Pearls for NEET-PG:** * **Couinaud Classification:** Remember that segments I, IVa, VII, and VIII are the "superior/posterior" segments, which are technically more challenging to resect. * **Glissonian Approach:** Often used in conjunction with tunneling to isolate pedicles deep within the liver. * **Makuuchi’s Procedure:** A classic reference for specialized hepatectomies involving deep segments. * **Key Rule:** Tunneling is for **deep/central** segments; standard resection is for **peripheral/anterior** segments (II, III, V, VI).

Practice by Chapter

Liver Anatomy and Physiology

Practice Questions

Benign Liver Lesions

Practice Questions

Liver Abscess

Practice Questions

Hepatocellular Carcinoma

Practice Questions

Metastatic Liver Disease

Practice Questions

Cirrhosis and Portal Hypertension

Practice Questions

Liver Trauma

Practice Questions

Cholelithiasis and Cholecystitis

Practice Questions

Choledocholithiasis

Practice Questions

Biliary Tract Tumors

Practice Questions

ERCP and Its Complications

Practice Questions

Liver Transplantation Basics

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free